Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Thyroid hormones help hair grow, reduce hair loss, and increase hair pigment.

DHT may increase the risk of heart disease and death in elderly men.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Skin problems are common in people with diabetes and controlling blood sugar can reduce these issues.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Hyperthyroidism can hide signs of high androgen levels in females.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.